Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
Sponsor: Uromedica
Summary
A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.
Official title: A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency
Key Details
Gender
FEMALE
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
167
Start Date
2021-01-26
Completion Date
2025-12-30
Last Updated
2024-07-23
Healthy Volunteers
No
Interventions
Adjustable Continence Therapy for Women (ACT)
Two ACT devices are implanted in each patient. The devices are intended for implantation in the paraurethral space, with the balloons located on each side of the urethra near the bladder neck. The ports are placed subcutaneously in the labia majora. The balloons are filled after implantation with an isotonic solution via needle injection into the port. The ACT implant can be placed using local, spinal or general anesthesia with the surgical instruments (provided separately).
Locations (2)
University of Colorado
Denver, Colorado, United States
CHI Health Research Center
Omaha, Nebraska, United States